Healthcare >> Analyst Interviews >> August 25, 2003

Opportunities In Biotechnology: Reni Benjamin – Rodman & Renshaw

RENI BENJAMIN, PhD, Dr. Reni Benjamin is a Senior Biotechnology Analyst at Rodman and Renshaw. Prior to joining Rodman, Dr. Benjamin was an associate analyst in Needham and Company's biotechnology equity research department. He earned his doctorate in Biochemistry by discovering and characterizing a novel gene implicated in germ cell development. His expertise includes biochemistry, functional genomics, gene therapy and molecular biology. Dr. Benjamin has presented at various regional and international conferences and published in peer-reviewed journals. Additionally, he has been cited in a variety of sources including the Wall Street Journal, Dow Jones Newswire, and Bloomberg. Dr. Benjamin received his Ph.D. from the University of Alabama at Birmingham and his Bachelors of Science degree in Biology from Allegheny College. Profile
TWST: Reni, you're putting on a biotech conference. Could you tell us

about that?

Dr. Benjamin: By way of background, Rodman & Renshaw is a full-service

investment bank with a focus on